ArticleJournal of epidemiology and community health2007
Use of statins and beta-blockers after acute myocardial infarction according to income and education.
Article in Journal of epidemiology and community health, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
37 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.
- Predictors of nonadherence to statins: a systematic review and meta-analysis.The Annals of pharmacotherapy · 2010Pooled it
- Article
- Myocardial infarction care in low and high socioeconomic environments: claims data analysis.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024Article
- Association of poverty-income ratio with cardiovascular disease and mortality in cancer survivors in the United States.PloS one · 2024Article
- Cross-sectional analysis of educational inequalities in primary prevention statin use in UK Biobank.Heart (British Cardiac Society) · 2022Article
- Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries.Diabetes care · 2022Article
- Reinitiation and Subsequent Discontinuation of Antiplatelet Treatment in Nonpersistent Older Patients with Peripheral Arterial Disease.Biomedicines · 2021Article
- Impact of Socioeconomic Factors and Gender on Refill Adherence and Persistence to Lipid-Lowering Therapy in Type 1 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2021Article
- Non-Persistence with Medication as a Mediator for the Social Inequality in Risk of Major Adverse Cardiovascular Events in Patients with Incident Acute Coronary Syndrome: A Nationwide Cohort Study.Clinical epidemiology · 2021Article
- Disparities in Statin Use in New York City: Implications for Health Reform.Journal of racial and ethnic health disparities · 2019Article
- Low socioeconomic status and depression: A double jeopardy for cardiovascular disease?Journal of psychosomatic research · 2019Article
- Improving long-term adherence to statin therapy: a qualitative study of GPs' experiences in primary care.The British journal of general practice : the journal of the Royal College of General Practitioners · 2018Article
- Review
- Explaining trends in coronary heart disease mortality in different socioeconomic groups in Denmark 1991-2007 using the IMPACTSEC model.PloS one · 2018Article
- Inequalities in medication adherence to statin treatment after stroke: A nationwide observational study.European stroke journal · 2016Article
- Time trends in statin utilisation and coronary mortality in Western European countries.BMJ open · 2016Article
- Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence.European journal of clinical pharmacology · 2016Article
- Sociodemographic and diagnostic characteristics of prescribing a second-line lipid-lowering medication: ezetimibe used as initial medication, switch from statins, or add-on medication.European journal of clinical pharmacology · 2015Article
- Article
- Outcomes after first percutaneous coronary intervention for acute myocardial infarction according to patient funding source.BMC health services research · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo study the initiation of and long-term refill persistency with statins and beta-blockers after acute myocardial infarction (AMI) according to income and education. DESIGN AND
settingLinkage of individuals through national registers of hospitalisations, drug dispensation, income and education.
participants30 078 patients aged 30-74 years surviving first hospitalisation for AMI in Denmark between 1995 and 2001.
main outcome measuresInitiation of statin or beta-blocker treatment (out-patient claim of prescriptions within 6 months of discharge) and refill persistency (first break in treatment lasting at least 90 days, and re-initiation of treatment after a break).
resultsWhen simultaneously estimating the effect of income and education on initiation of treatment, the effect of education attenuated and a clear income gradient remained for both drugs. Among patients aged 30-64 years, high income (adjusted hazard ratio (HR) 1.27; 95% confidence interval (CI) 1.19-1.35) and medium income (HR 1.13; 95% CI 1.06-1.20) was associated with initiation of statin treatment compared with low income. The risk of break in statin treatment was lower for patients with high (HR 0.73; 95% CI 0.66-0.82) and medium (HR 0.82; 95% CI 0.74-0.92) income compared with low income, whereas there was a trend in the opposite direction concerning a break in beta-blocker treatment. There was no gradient in re-initiation of treatment.
conclusionPatients with low compared with high income less frequently initiated preventive treatment post-AMI, had worse long-term persistency with statins, but tended to have better persistency with beta-blockers. Low income by itself seems not to be associated with poor long-term refill persistency post-AMI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.